NCT02093819View on ClinicalTrials.gov

To Assess Safety, Tolerability and Pharmacokinetics of BI 416970 in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Healthy
Interventions
DRUG

Placebo to BI 416970

single rising doses

DRUG

BI 416970

single rising doses

Trial Locations (1)

Unknown

1345.1.1 Boehringer Ingelheim Investigational Site, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02093819 - To Assess Safety, Tolerability and Pharmacokinetics of BI 416970 in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter